Global Autoimmune Drugs Market 2016-2020


#668446

137pages

Technavio

$ 2500

In Stock

About Autoimmune Diseases Drugs

Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidneys, glands, and joints.
Autoimmune diseases occur due to genetic, infectious, or environmental factors. There are over 80 autoimmune diseases, including AS, IBD (CD and UC), MS, RA, SLE, and PsA. DMARDs, NSAIDs, corticosteroids, analgesics, and immunosuppressants are the major drug classes used to treat autoimmune diseases.

Technavios analysts forecast the global autoimmune diseases drugs market to grow at a CAGR of 5.57% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global autoimmune diseases drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of autoimmune diseases.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Autoimmune Diseases Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AbbVie Inc.
Amgen Inc.
Biogen
F. Hoffmann-La Roche
Johnson & Johnson Private Limited
Pfizer Inc.

Other prominent vendors
Ablynx
AB Science
Acorda Therapeutics
Alder BioPharmaceuticals
Antares Pharma
Astellas Pharma
AstraZeneca
Baxter
Boehringer Ingelheim
Can-Fite BioPharma
Celgene
Celltrion
ChemoCentryx
Coherus BioSciences
Daiichi Sankyo
Eisai
Eli Lilly
Gilead Sciences
GSK
Hospira
Idera Pharmaceuticals
Immunomedics
ImmuPharma
Incyte
Invion
KaloBios Pharmaceuticals
Lexicon Pharmaceuticals
Merck
MedImmune
Morphotek
Novo Nordisk
Novartis
Opexa Therapeutics
Principia Biopharma
Regeneron Pharmaceuticals
Sandoz
Sanofi
Santarus
Takeda Pharmaceuticals
UCB
Vaccinex
Vertex Pharmaceuticals
Vitae Pharmaceuticals

Market driver
Promising pipeline
For a full, detailed list, view our report

Market challenge
Loss of patent exclusivity of branded therapies
For a full, detailed list, view our report

Market trend
Increase in public awareness programs
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.